Screener
Aclaris Therapeutics ACRS Invested capital
Discontinued — last reported Q2 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Aclaris Therapeutics’s reported figures.
The source filing: Aclaris Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:31 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-092065
FAQ
- What is Aclaris Therapeutics's invested capital?
- Aclaris Therapeutics (ACRS) reported invested capital of $107.26M in Q2 2026.
- How has Aclaris Therapeutics's invested capital changed year-over-year?
- Aclaris Therapeutics's invested capital decreased by 1.3% year-over-year, from $108.7M to $107.26M.
- What is the long-term trend for Aclaris Therapeutics's invested capital?
- Over 5 years (2020 to 2025), Aclaris Therapeutics's invested capital has grown at a 23.4% compound annual growth rate (CAGR), from $29.74M to $85.24M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Aclaris Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude